Torrey Path announced today that it has joined Accelrys Inc’s (Nasdaq: ACCL) Independent Software Vendors (ISV) alliance program. As a member of the program, Torrey Path will sell applications for delivery of and reporting on biological data that use Accelrys’ industry leading Pipeline Pilot software platform. Read the rest of this entry »
(Reprinted from the 2009 San Diego Software Industry Council annual whitepaper: online at http://www.sdsic.org.)
At Torrey Path, a dominant feature that we see in our industry is the scale of the data involved. Most disciplines in life sciences are highly observational, and there is a lot to observe. Established scanning technologies, such as gene expression microarrays, can easily generate gigabytes of data, and new technologies like next-generation sequencing or functional MRI can produce data on the terabyte scale and beyond. Great new analytics are being developed and applied to making sense of all of the data being produced; some of them locally in San Diego. However, due to the scale and complexity of the data being generated, we continue to see a growing disconnection between the data analyses and the life sciences researchers who are trying to use these data to generate new knowledge. That’s where Torrey Path comes in.
Torrey Path is focused on assembling experimental biological data along with basic, supporting knowledge, and then running biostatistical analyses in bulk across all of the data. Processing just a few experiments this way can take days, so for many analytical techniques it makes economic sense to do it only once at our data center, rather than having our customers do that processing repeatedly and on an ad hoc basis. Other techniques might be more sensitive to end-user input, but even in these cases our customers can benefit from knowing what experiments and what samples might make the most sense to start with. We’ve invested heavily in the processing pipeline, making it so we can add new types of data and new analytical techniques at various points in the process.
The quantity of data we are handling turns out to have not just a numerical effect on the processor times and storage capacities, but an even stronger, qualitative effect on the value chain of analytics and transforming raw data into consumable, sustainable knowledge resources.
Torrey Path, Inc., a leading-edge biological data and biodata solutions developer, announced today that it has formed a technical partnership with the John McNeil and Company, Inc., makers of the LabSynch Laboratory Information Management System (LIMS) and provider of related custom development services.
Sirimon O-Charoen, PhD, Senior Research Scientist for Torrey Path, will present a talk at Accelrys’ 2009 European User Group Conference this October. Dr. O-Charoen will discuss findings in glaucoma made analyzing Torrey Path’s Eye Content Pack using Accelrys’ Pipeline Pilot tools. Read the rest of this entry »
Torrey Path will be exhibiting at BioIT World Conference & Expo ‘09 Tuesday and Wednesday April 28-29, 2009. Read the rest of this entry »
Torrey Path will present “Genomes in Action” at the San Diego Science Festival on Saturday April 4th, 2009. Participants will find out how their genomes, the human genome, are used to diagnose disease and discover therapies. Read the rest of this entry »
Torrey Path was awarded Best Business Model in a presentation by the New Enterprise Forum based in Michigan. Presented on February 19th, 2009, the award recognizes CEO Peter Dresslar’s presentation to the NEF during the previous year.
Check out our Careers Page for the latest update on Torrey Path job openings. We are looking for contract developers to join our offices here, as well as new personnel for a new overseas operation.
Torrey Path is pleased to announce the scheduled release of three new content packs for 2009: Metabolic Content Pack, Cardiovascular Content Pack, and Neurology Content Pack. Content Packs are deep dives into microarray data in specific therapeutic areas. They provide hand-annotated experimental data, discipline-specific controlled vocabulary groups, and a variety of pre-computed biostatistical data. Read the rest of this entry »
Torrey Path has been selected to present at the New Enterprise Forum Annual Awards meeting. Peter Dresslar, Torrey Path CEO, will be the presenter.